Inflammation Care

Inflammation Care

Inflammation plays a critical role in the pathogenesis of numerous diseases, making the pursuit of effective anti-inflammatory interventions of paramount importance. Oligo Fucoidan has exhibited a spectrum of biological activities encompassing antioxidant, immunomodulatory, and anti-inflammatory effects. Its capacity for mitigating inflammation likely involves intricate interactions across cellular and molecular levels, encompassing the suppression of inflammatory cell activation, modulation of inflammatory mediator release, and perturbation of inflammatory signaling pathways. Importantly, inflammation is closely intertwined with the fibrotic process, whereby chronic inflammation can trigger tissue remodeling and fibrosis. By modulating inflammation, Oligo Fucoidan may contribute to the prevention of fibrosis in disease states.

Potential Benefits of Oligo Fucoidan in Inflammation Care

  • Exhibit anti-inflammatory activity
  • Attribute to the down-regulation of inflammatory cytokines
  • Contribute to the prevention of fibrosis in disease states
  • Reduce the proportion of lymphocytes and the concentration of inflammatory factors in patients with asthma to inhibit inflammation of the respiratory tract and increase pulmonary function

Hi-Q’s Publications in Inflammation Care Research

2021 Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
2020 Oligo-Fucoidan Improves Diabetes-Induced Renal Fibrosis via Activation of Sirt-1, GLP-1R, and Nrf2/HO-1: An In Vitro and In Vivo Study
2020 Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model
2020 Protective Effect of Low‐Molecular‐Weight Fucoidan on Radiation‐Induced Fibrosis Through TGF‐β1/Smad Pathway‐Mediated Inhibition of Collagen I Accumulation
2020 Radioprotective Effect of Self-Assembled Low Molecular Weight Fucoidan–Chitosan Nanoparticles
2018 Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues
2016 Low-Molecular-Weight Fucoidan and High-Stability Fucoxanthin from Brown Seaweed Exert Prebiotics and Anti-Inflammatory Activities in Caco-2 Cells
2015 Inhibitory activity of Sargassum Hemiphyllum Sulfated Polysaccharide in Arachidonic Acid-Induced Animal Models of Inflammation
2011 Inhibition of Lipopolysaccharide (LPS)-Induced Inflammatory Responses by Sargassum hemiphyllum Sulfated Polysaccharide Extract in RAW 264.7 Macrophage Cells
*The Fucoidan and Fucoxanthin used in these studies were prepared by Hi-Q Marine Biotech